NuvOx Pharma Announces Issuance of New Patent Covering a New Method of Treating Cancer

Tucson, AZ, July 23, 2021 --( NuvOx Pharma, a privately-held clinical-stage biotechnology company based in Tucson, Arizona, has further expanded its patent portfolio in oxygen therapeutics with the issuance of US Patent No. 10946097, “Fractionated radiotherapy and chemotherapy with an oxygen therapeutic,” describing a new method of treating cancer utilizing Company’s lead drug candidate, NanO2TM, and its administration to reverse tumor hypoxia.

Click here to read more

Recent Posts

See All